Identification of 5-fluorouracil-inducible target genes using cDNA microarray profiling

Cancer Research

Volumn 63, Issue 15, 2003, Pages 4602-4606

  Maxwell, Pamela J ^a   Longley, Daniel B ^a   Latif, Tariq ^a   Boyer, John ^a   Allen, Wendy ^a   Lynch, Maria ^a   McDermott, Ultan ^a   Paul Harkin, D ^a   Allegra, Carmen J ^b   Johnston, Patrick G ^a,c  

^a QUEEN'S UNIVERSITY BELFAST   (United Kingdom)

^b NATIONAL CANCER INSTITUTE   (United States)

^c BELFAST CITY HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ACYLTRANSFERASE; BIOLOGICAL MARKER; CELL SURFACE PROTEIN; CHAPERONIN; COMPLEMENTARY DNA; FLUOROURACIL; LIPOCORTIN 2; MESSENGER RNA; OXALIPLATIN; PROTEIN MAT 8; PROTEIN P53; RALTITREXED; RIBOSOME RNA; SPERMINE SPERMIDINE ACETYLTRANSFERASE; THYMOSIN BETA10; UNCLASSIFIED DRUG;

ARTICLE; BREAST CANCER; CANCER CHEMOTHERAPY; CELL STRAIN MCF 7; COLORECTAL CANCER; CONTROLLED STUDY; DNA MICROARRAY; DRUG RESPONSE; GENE EXPRESSION; GENE IDENTIFICATION; GENE INDUCTION; GENE TARGETING; GENETIC TRANSCRIPTION; HUMAN; HUMAN CELL; NORTHERN BLOTTING; PRIORITY JOURNAL; WESTERN BLOTTING;

ANTIMETABOLITES, ANTINEOPLASTIC; BLOTTING, SOUTHERN; BREAST NEOPLASMS; DRUG RESISTANCE, NEOPLASM; FLUOROURACIL; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION, NEOPLASTIC; GENE SILENCING; GENES, P53; HUMANS; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; ORGANOPLATINUM COMPOUNDS; TRANS-ACTIVATION (GENETICS); TUMOR CELLS, CULTURED;

EID: 0043136753     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (20)

1. Longley, D. B., Harkin, D. P., and Johnston, P. G. 5-Fluorouracil: mechanisms of action and clinical strategies. Nat. Rev. Cancer, 3: 330-338, 2003.
2. Johnston, P. G., Drake, J. C., Trepel, J., and Allegra, C. J. Immunological quantitation of thymidylate synthase using the monoclonal antibody TS 106 in 5-fluorouracil-sensitive and -resistant human cancer cell lines. Cancer Res., 52, 4306-4312, 1992.
3. Longley, D. B., Boyer, J., Allen, W. L., Latif, T., Ferguson, P. R., Maxwell, P. J., McDermott, U., Lynch, M., Harkin, D. P., and Johnston, P. G. The role of thymidylate synthase induction in modulating p53-regulated gene expression in response to 5-fluorouracil and antifolates. Cancer Res., 62: 2644-2649, 2002.
4. Hegardt, C., Johannsson, O. T., and Oredsson, S. M. Rapid caspase-dependent cell death in cultured human breast cancer cells induced by the polyamine analogue N(I), N(II)-diethylnorspermine. Eur. J. Biochem., 269: 1033-1039, 2002.
5. Chiang, Y., Rizzino, A., Sibenaller, Z, A., Wold, M. S., and Vishwanatha, J. K. Specific down-regulation of annexin II expression in human cells interferes with cell proliferation. Mol. Cell. Biochem. 199: 139-147, 1999.
6. Hall, A. K. Thymosin beta-10 accelerates apoptosis. Cell. Mol. Biol. Res., 41: 167-180, 1995.
7. Morrison, B. W., Mooreman, J. R., Kowdley, G. C., Kobayashi, Y. M., Jones, L. R., and Leder. P. Mat-8, a novel phospholemman-like protein expressed in human breast tumors, induces chloride conductance in Xenopus oocytes. J. Biol. Chem., 270: 2176-2182, 1995.
8. Hohfeld, J., and Hartl, F. U. Role of the chaperonin cofactor Hsp10 in protein folding and sorting in yeast mitochondria. J. Cell Biol., 126: 305-315, 1994.
9. Hughes, L. R., Stephens, T. C., Boyle, F. T., and Jackman, A. L. Raltitrexed (Tomudex) a highly polyglutamatable antifolate Thymidylate synthase inhibitor. In: A. L. Jackman (ed.), Antifolate Drugs in Cancer Therapy, pp. 147-165. Totowa. New Jersey: Humana Press, 1999.
10. Cvitkovic, E., and Bekradda. M. Oxaliplatin: a new therapeutic option in colorectal cancer. Semin. Oncol., 26: 647-662, 1999.
11. Giacchetti, S., Perpoint, B., Zidani, R., Le Bail, N., Faggiuolo, R., Focan, C., Chollet, P., Llory, J. F., Letourneau, Y., Coudert, B., Bertheaut-Cvitkovic, F., Larregain-Fournier, D., Le Rol, A., Walter, S., Adam, R., Misset, J. L., and Levi, F. Phase III multicenter randomized trial of oxaliplatin added to chronomodulated fluorouracil-leucovorin as first-line treatment of metastatic colorectal cancer. J. Clin. Oncol., 18: 136-147, 2000.
12. Wingender, E., Chen, X., Hehl, R., Karas, H., Liebich, I., Marys, V., Meinhardt, T., Pruss, M., Reuter, I., and Schacherer, F. TRANSFAC: an integrated system for gene expression regulation. Nucleic Acids Res., 28: 316-319, 2000.
13. Kudoh, K., Ramanna, M., Ravatn, R., Elkahloun, A. G., Bittner, M. L., Meltzer, P. S., Trent, J. M., Dalton, W. S., and Chin, K. V. Monitoring the expression profiles of doxorubicin-induced and doxorubicin-resistant cancer cells by cDNA microarray. Cancer Res., 60: 4161-4166, 2000.
14. Kihara, C., Tsunoda, T., Tanaka, T., Yamana, H., Furukawa, Y., Ono, K., Kitahara, O., Zembutsu, H., Yanagawa, R., Hirata, K., Takagi, T., and Nakamura, Y. Prediction of sensitivity of esophageal tumors to adjuvant chemotherapy by cDNA microarray analysis of gene-expression profiles. Cancer Res., 61: 6474-6479, 2001.
15. Sotiriou, C., Powles, T. J., Dowsett, M., Jazaeri, A. A., Feldman, A. L., Assersohn, L., Gadisetti, C., Libutti, S. K., and Liu, E. T. Gene expression profiles derived from fine needle aspiration correlate with response to systemic chemotherapy in breast cancer. Breast Cancer Res., 4: R3, 2002.
16. Zembutsu, H., Ohnishi, Y., Tsunoda, T., Furukawa, Y., Katagiri, T., Ueyama, Y., Tamaoki, N., Nomura, T., Kitahara, O., Yanagawa, R., Hirata, K., and Nakamura, Y. Genome-wide cDNA microarray screening to correlate gene expression profiles with sensitivity of 85 human cancer xenografts to anticancer drugs. Cancer Res., 62: 518-527, 2002.
17. Scherf, U., Ross, D. T., Waltham, M., Smith, L. H., Lee, J. K., Tanabe, L., Kohn, K. W., Reinhold, W. C., Myers, T. G., Andrews, D. T., Scudiero, D. A., Eisen, M. B., Sausville, E. A., Pommier, Y., Botstein, D., Brown, P. O., and Weinstein, J. N. A gene expression database for the molecular pharmacology of cancer. Nat. Genet., 24: 236-244, 2000.
18. Yu, F. X., Lin, S. C., Morrison-Bogorad, M., Atkinson, M. A., and Yin, H. L. Thymosin beta 10 and thymosin beta 4 are both actin monomer sequestering proteins. J. Biol. Chem., 268: 502-509, 1993.
19. Sweadner, K. J., and Rael, E. The FXYD family of small ion transport regulators or channels: cDNA, sequence, protein signature sequence and expression. Genomics, 68: 41-56, 2000.
20. Wang, W., Marsh, S., Cassidy, J., and McLeod, H. L. Pharmacogenomic dissection of resistance to thymidylate synthase inhibitors. Cancer Res., 61: 5505-5510, 2001.